Huayi Biotechnology

Tirzepatide

70 tests · latest 06 Jun 2026

92%

NEA rating

#1 of 23 Tirzepatide vendors

20 of 21 classifiable tests passed

natural 96% · customers 4.3★ (32)

NEA analysis · Tirzepatide

Huayi Biotechnology Tirzepatide is a category leader: purity holds at 99.3% and fill sits right on the label at 99.4%. Recent lots pass identity cleanly with documented batches and no material variance.

Purity focus — purity 99.5%+, dose ±35%methodology

Peptides

3 rated · tap to focus

#	Peptide	Rating	N
1	Tirzepatideselected	92%	21
2	Sermorelin	91%	31
3	GHK Cu	90%	18

Rating trend

Tirzepatide rating from this vendor, after each test

Huayi Biotechnology Tirzepatide test history

21 tests · 20 pass · 1 fail

COA-backed lab tests

Date	Result	Purity	Dosage	Label
6 Jun 2026	Pass	99.9%Identity Pass	-0.9%14.87 mg tested / 15 mg label	Batch TI202621sent by Public
27 May 2026	Pass	98.8%Identity Pass	+0.9%15.13 mg tested / 15 mg label	Batch TI202620sent by Public
11 May 2026	Pass	99.9%Identity Pass	-0.8%14.88 mg tested / 15 mg label	Batch TI202619sent by Public
14 Apr 2026	Fail	99.9%Content Fail	-12.3%13.15 mg tested / 15 mg label	Batch TI202618sent by Vendor
22 Mar 2026	Pass	99.3%Identity Pass	+0.9%15.13 mg tested / 15 mg label	Batch TI202617sent by Public
11 Mar 2026	Pass	99.9%Identity Pass	-0.7%14.89 mg tested / 15 mg label	Batch TI202616sent by Vendor
16 Feb 2026	Pass	98.6%Identity Pass	+0.2%15.03 mg tested / 15 mg label	Batch TI202615sent by Public
8 Feb 2026	Pass	98.5%Identity Pass	-1.6%14.76 mg tested / 15 mg label	Batch TI202614sent by Public
14 Jan 2026	Pass	99.6%Identity Pass	-1.4%14.79 mg tested / 15 mg label	Batch TI202613sent by Vendor
1 Jan 2026	Pass	98.5%Identity Pass	-0.1%14.98 mg tested / 15 mg label	Batch TI202612sent by Public

1-10 of 21

← All vendors